Emma J. K. Kowal

Emma J. K. Kowal

Auto-generated profile, based on publicly available information

Emma J. K. Kowal

Department of Biology, Massachusetts Institute of Technology, Cambridge MA 02142 USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
BMBogdan Mateescu
Bogdan Mateescu
EKEmma J. K. Kowal
Emma J. K. Kowal
BBBas W. M. van Balkom
Bas W. M. van Balkom
SBSabine Bartel
Sabine Bartel
SBSuvendra N. Bhattacharyya
Suvendra N. Bhattacharyya
EHEsther N. M. Nolte‐'T Hoen
Esther N. M. Nolte‐'T Hoen
The release of RNA‐containing extracellular vesicles (EV) into the extracellular milieu has been demonstrated in a multitude of different in vitro cell systems and in a variety of body fluids. RNA‐containing EV are in the limelight for their capacity to communicate genetically encoded messages to other cells, their suitability as candidate biomarkers for diseases, and their use as therapeutic agents. Although EV‐RNA has attracted enormous interest from basic researchers, clinicians, and industry, we currently have limited knowledge on which mechanisms drive and regulate RNA incorporation into EV and on how RNA‐encoded messages affect signalling processes in EV‐targeted cells. Moreover, EV‐RNA research faces various technical challenges, such as standardisation of EV isolation methods, optimisation of methodologies to isolate and characterise minute quantities of RNA found in EV, and development of approaches to demonstrate functional transfer of EV‐RNA in vivo. These topics were discussed at the 2015 EV‐RNA workshop of the International Society for Extracellular Vesicles. This position paper was written by the participants of the workshop not only to give an overview of the current state of knowledge in the field, but also to clarify that our incomplete knowledge – of the nature of EV(‐RNA)s and of how to effectively and reliably study them – currently prohibits the implementation of gold standards in EV‐RNA research. In addition, this paper creates awareness of possibilities and limitations of currently used strategies to investigate EV‐RNA and calls for caution in interpretation of the obtained data.

23 May 2016 in Nature Methods
Verified
Journal Article
Open access
PDF file
ACAlejandro Chavez
Alejandro Chavez
MTMarcelle Tuttle
Marcelle Tuttle
BPBenjamin W Pruitt
Benjamin W Pruitt
BEBen Ewen-Campen
Ben Ewen-Campen
RCRaj Chari
Raj Chari
GCGeorge Church
George Church
A comparison of seven dCas9-based transcriptional activators shows that VPR, SAM, and Suntag perform best in cell lines from a variety of organisms. Several programmable transcription factors exist based on the versatile Cas9 protein, yet their relative potency and effectiveness across various cell types and species remain unexplored. Here, we compare Cas9 activator systems and examine their ability to induce robust gene expression in several human, mouse, and fly cell lines. We also explore the potential for improved activation through the combination of the most potent activator systems, and we assess the role of cooperativity in maximizing gene expression.

7 September 2015 in Nature Methods
Verified
Journal Article
Open access
PDF file
SKSamira Kiani
Samira Kiani
ACAlejandro Chavez
Alejandro Chavez
MTMarcelle Tuttle
Marcelle Tuttle
RHRichard N Hall
Richard N Hall
RCRaj Chari
Raj Chari
GCGeorge Church
George Church
The length of a single guide RNA (gRNA) determines the function of Cas9. In this study 20-nt gRNAs allowed nuclease activity and genome editing, whereas 14-nt gRNAs mediated transcriptional activation or repression. We demonstrate that by altering the length of Cas9-associated guide RNA (gRNA) we were able to control Cas9 nuclease activity and simultaneously perform genome editing and transcriptional regulation with a single Cas9 protein. We exploited these principles to engineer mammalian synthetic circuits with combined transcriptional regulation and kill functions governed by a single multifunctional Cas9 protein.

22 August 2017
Verified
Book Chapter
Closed access
PDF file
EKEmma J. K. Kowal
Emma J. K. Kowal
DTDmitry Ter-Ovanesyan
Dmitry Ter-Ovanesyan
ARAviv Regev
Aviv Regev
GCGeorge Church
George Church

22 August 2017
Verified
Book Chapter
Closed access
PDF file
DTDmitry Ter-Ovanesyan
Dmitry Ter-Ovanesyan
EKEmma J. K. Kowal
Emma J. K. Kowal
ARAviv Regev
Aviv Regev
GCGeorge Church
George Church
ECEmanuele Cocucci
Emanuele Cocucci

8 February 2025 in Nucleic Acids Research
Verified
Journal Article
Open access
EKEmma J K Kowal
Emma J K Kowal
YSYuta Sakai
Yuta Sakai
MMMichael P McGurk
Michael P McGurk
ZPZoe J Pasetsky
Zoe J Pasetsky
CBChristopher B Burge
Christopher B Burge
Spliceosomal introns are a ubiquitous feature of eukaryotic genes, whose presence often boosts the expression of their host gene, a phenomenon known as intron-mediated enhancement (IME). IME has been noted across diverse genes and organisms but remains mysterious in many respects. For example, how does intron sequence affect the magnitude of IME? In this study, we performed a massively parallel reporter assay (MPRA) to assess the effect of varying intron sequence on gene expression in a high-throughput manner, in human cells, using tens of thousands of synthetic introns with natural splice sites and randomized internal sequence. We observe that most random introns splice efficiently and enhance gene expression as well as or better than fully natural introns. Nearly all introns stimulate gene expression ∼eight-fold above an intronless control, at both mRNA and protein levels, suggesting that the primary mechanism acts to increase mRNA levels. IME strength is positively associated with splicing efficiency and with the intronic content of poly-uridine stretches, which we confirm using reporter experiments. In sum, this work assesses the IME of a diverse library of introns and uncovers sequence-dependent aspects, but suggests that enhancement of gene expression is a general property of splicing, largely independent of intron sequence.